Juvenile Hemochromatosis, Genetic Study and Long-term Follow up after Therapy

Masoud M Malekzadeh1, Amir Reza Radmard2, Alireza Nouroozi3

  • 1Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Insights

This study identifies a novel HJV mutation in a family with juvenile hemochromatosis (JH), a rare iron overload disorder. Molecular genetic analysis is crucial for diagnosing and managing JH, even in cases negative for HFE mutations.

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Hereditary hemochromatosis (HH) is rare in Iran, with previous cases lacking HFE mutations.
  • Juvenile hemochromatosis (JH) is a severe form requiring accurate diagnosis.
  • This study investigates a family with suspected JH and negative HFE mutation status.

Purpose of the Study:

  • To perform a detailed molecular study of a family affected by severe juvenile hemochromatosis.
  • To identify the genetic basis of JH in a family with no reported HFE mutations.
  • To evaluate the utility of genetic analysis in diagnosing and managing JH.

Main Methods:

  • Pedigree analysis and clinical follow-up of affected siblings over 3 years.
  • Microsatellite analysis and comprehensive gene sequencing of HH-related genes.
  • Exclusion of mutations in HAMP, TfR2, and FPN genes.

Main Results:

  • Two siblings diagnosed with clinical JH exhibited homozygosity for the HJV c.265T>C (p.C89R) mutation.
  • The proband also carried a heterozygous HFE c.884T>C (p.V295A) mutation.
  • A homozygous HJV polymorphic variant (c.98-6C>G) was identified in affected siblings.

Conclusions:

  • Molecular analysis of HH-related genes is essential for accurate JH diagnosis.
  • Genetic findings, combined with MRI and elastography, aid in JH management and follow-up.
  • This study highlights the HJV gene as a significant factor in non-HFE hereditary hemochromatosis.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.7K
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
41
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
26